Moderna's stock surged over 180% on positive Phase 3 cancer treatment trial results, with the creator promising a valuation analysis and potential investment insights by the end of the video.
Source Post
🔴MODERNA: La Revolución del Cáncer ¿A QUÉ PRECIO vale la pena INVERTIR?🤔 | 👉VALORACIÓN 2026Q3
Aug 27, 2026
The creator discusses Moderna's stock performance, which surged over 180% in a single session due to positive Phase 3 trial results for a skin cancer treatment developed in collaboration with Merck. The video aims to analyze these advancements, their implications for the stock, and provide an updated valuation for Moderna, including the potential of its cancer treatments. The creator notes that Moderna is not a classic value investment due to its expected lack of positive operating profit in the coming years.
Linked Mentions
Tickers discussed in this post
Merck's stock also saw a positive impact, rising 11% due to the collaboration on a cancer treatment with Moderna.
Linked Signals
Tracked calls opened from this post
No linked signals were opened directly from this post.